Mantle Cell Lymphoma (MCL) Terminated Phase 1 Trials for Rituximab (DB00073)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00022971Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic LeukemiaTreatment